BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Reports Strong Correlation for Finger-Prick Nu.Q NETs Prototype in Sepsis Patients 

VolitionRx Limited (NYSE American: VNRX), a multinational epigenetics company, announced that results using its lateral flow finger-prick prototype were highly correlated with results from its established automated Nu.Q NETs test in critically ill sepsis patients, supporting the potential expansion of nucleosome testing beyond centralized laboratories. The company said the lateral flow test could enable rapid identification of high-risk patients in […]